Hand-foot syndrome and its impact on daily activities in breast cancer patients receiving docetaxel-based chemotherapy
| Autor: | Yu-Fen Lin, Chao-Hui Wang, Wen-Chi Shen, Ya-Hui Hsu, Shu-Ching Chen |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
medicine.medical_specialty Activities of daily living medicine.medical_treatment Taiwan Antineoplastic Agents Breast Neoplasms Docetaxel 03 medical and health sciences 0302 clinical medicine Breast cancer Surveys and Questionnaires Internal medicine Activities of Daily Living Humans Medicine Outpatient clinic Capecitabine Chemotherapy Foot symptoms integumentary system 030504 nursing Oncology (nursing) business.industry General Medicine Middle Aged medicine.disease humanities Hand-Foot Syndrome body regions Cross-Sectional Studies 030220 oncology & carcinogenesis Female 0305 other medical science business medicine.drug Patient education |
| Zdroj: | European Journal of Oncology Nursing. 43:101670 |
| ISSN: | 1462-3889 |
| DOI: | 10.1016/j.ejon.2019.09.011 |
| Popis: | Purpose Breast cancer patients who undergo docetaxel-based chemotherapy regimens can have hand-foot syndrome (HFS), which negatively impacts their ability to perform daily activities. The purpose of the study was to assess, in breast cancer patients receiving chemotherapy: the perceived levels of HFS-related symptoms of the feet, hands or fingers; and HFS-related restrictions in daily activities; as well as to identify factors associated with these symptoms and restrictions. Methods This cross-sectional study examined breast cancer patients who received docetaxel-based chemotherapy from the general surgery outpatient department and oncology outpatient department of a medical center in northern Taiwan. A set of structured questionnaires were used to measure patients’ HFS-related symptoms and HFS-related restrictions in daily activities. Results Of the 85 breast cancer patients studied, 41.2% reported HFS. Patients had higher level of HFS-related foot symptoms than HFS-related hand or fingers symptoms. Greater restriction in HFS-related daily activities was associated with more HFS-related hand or fingers symptoms and more HFS-related foot symptoms; these factors explained 44.7% of the variance in restriction of activities. Conclusion Skin care and patient education should be provided to manage the HFS of breast cancer patients receiving chemotherapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect